Highlights XOMA Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
26.5 ^USD	+4.29%		+2.63%	+43.24%

Apr. 29	Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target	MT
Apr. 03	XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..	Apr. 02	CI
XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08	CI
XOMA Agrees to Acquire Kinnate Biopharma	Feb. 16	MT
XOMA Corporation entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. for approximately $120 million.	Feb. 15	CI
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.	Jan. 17	CI
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	Jan. 11	DJ
XOMA Authorizes $50 Million Share Buyback Program	Jan. 02	MT
XOMA Authorizes $50 Million Share Buyback Program	Jan. 02	MT
XOMA Corporation announces an Equity Buyback for $50 million worth of its shares.	Jan. 02	CI
XOMA Corporation authorizes a Buyback Plan.	Jan. 01	CI
XOMA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (XOMA) XOMA CORPORATION Reports Q3 Revenue $830,000	Nov. 07	MT
ObsEva to Return Global Rights on Ebopiprant to Xoma	23-10-30	MT
Earnings Flash (XOMA) XOMA CORPORATION Posts Q2 Revenue $1.7M	23-08-08	MT
XOMA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
XOMA Acquires Royalty, Milestone Rights for Two Assets From LadRx	23-06-22	MT
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Earnings Flash (XOMA) XOMA CORPORATION Posts Q1 Revenue $437,000	23-05-09	MT
XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
XOMA Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights XOMA Corporation

Equities

XOMA

US98419J2069

Highlights

Filters